• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Kazia Therapeutics Sells Cantrixil IP and Trademarks for Cantrixil

    PR NEWSWIRE

    Lonza signs manufacturing agreement with Oasmia for ovarian cancer drug

    REUTERS

    Kazia Licenses Cantrixil, a Clinical-stage Ovarian Cancer Drug, to Oasmia

    PRNASIA

    Oasmia acquires rights to cancer drug candidate Cantrixil in $44m deal

    PHARMAFILE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.